Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - InforMax, Inc. (NasdaqNM:INMX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
Aug  2Conference call: Informax Earnings (Q2 2001)
Location
7600 Wisconsin Avenue, 11th Floor
Bethesda, MD 20814
Phone: (240) 747-4000
Fax: (240) 223-0025
Employees (last reported count): 244
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Software & Programming
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 74%
·Over the last 6 months:
 · 3 insider sells; 2.41M shares
  (11.8% of insider shares)
·Institutional: 39% (150% of float)
(40 institutions)
·Net Inst. Selling: 353.0K shares (+3.89%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
InforMax Inc. is a global provider of bioinformatic software solutions, involving the application of information technology to the analysis of genomic, proteomic and other biomolecular data. The Company's bioinformatic software solutions are designed to enable researchers to more efficiently search, organize, share, analyze and interpret these data that form the genetic blueprint of all organisms. As a result, the Company's solutions allow researchers to reduce the time it takes to discover and validate biological targets that may lead to new therapeutics, diagnostics or biomolecular interventions to cure or prevent disease.
More from Market Guide: Expanded Business Description

Financial Summary
InforMax, Inc. is a global provider of bioinformatic software solutions for the analysis and interpretation of genomic, proteomic and other biomolecular data. For the six months ended 6/30/01, revenues totalled $14.2 million, up from $6.5 million. Net loss applicable to Common rose 29% to $8.1 million. Revenues reflect an increase in Vector NTI Suite sales and increased demand for the GenoMax enterprise product. Higher loss reflects an increase in salaries and benefits.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Alex Titomirov, Ph.D., 41
Chairman, CEO
$367K$13.8M
James Bernstein, M.D., 62
Pres, COO, Director
325K1.2M
John Green, 49
CFO, Sr. VP-Fin. and Admin.
--  --  
Timothy Sullivan, 41
Sr. VP of Sales and Marketing
348K513K
Stephen Lincoln, 36
Sr. VP of Product Devel..
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:INMXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 3-May-2001
$2.85 
Recent Price$4.44 
52-Week High
on 7-Nov-2000
$31.75 
Daily Volume (3-month avg)186.5K
Daily Volume (10-day avg)131.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
26-Week Change-49.3%
26-Week Change
relative to S&P500
-44.8%
Share-Related Items
Market Capitalization$107.9M
Shares Outstanding24.3M
Float6.30M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$3.51 
Earnings (ttm)-$2.06 
Earnings (mrq)-$0.17 
Sales (ttm)$1.43 
Cash (mrq)$2.90 
Valuation Ratios
Price/Book (mrq)1.26 
Price/EarningsN/A 
Price/Sales (ttm)3.10 
Income Statements
Sales (ttm)$24.8M
EBITDA (ttm)-$13.1M
Income available to common (ttm)-$22.9M
Profitability
Profit Margin (ttm)-51.1%
Operating Margin (ttm)-64.2%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-19.46%
Return on Equity (ttm)-44.53%
Financial Strength
Current Ratio (mrq)9.05 
Debt/Equity (mrq)0.02 
Total Cash (mrq)$70.4M
Short Interest
As of 8-Aug-2001
Shares Short543.0K
Percent of Float8.6%
Shares Short
(Prior Month)
513.0K
Short Ratio7.44 
Daily Volume73.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.